NeuBase Therapeutics Inc (NBSE)
0.405
-0.01
(-1.72%)
USD |
NASDAQ |
May 03, 16:00
0.376
-0.03
(-7.16%)
After-Hours: 20:00
NeuBase Therapeutics PS Ratio
PS Ratio Chart
Historical PS Ratio Data
| Date | Value |
|---|---|
| October 31, 2005 | 2.260 |
| October 24, 2005 | 2.238 |
| September 30, 2005 | 2.475 |
| August 31, 2005 | 2.688 |
| July 29, 2005 | 2.337 |
| July 05, 2005 | 2.337 |
| June 30, 2005 | 2.337 |
| June 10, 2005 | 2.507 |
| June 09, 2005 | 1.254 |
| June 02, 2005 | 2.006 |
| May 09, 2005 | 2.909 |
| May 03, 2005 | 3.009 |
| April 28, 2005 | 2.758 |
| Date | Value |
|---|---|
| April 18, 2005 | 2.758 |
| March 31, 2005 | 3.054 |
| March 29, 2005 | 3.283 |
| February 14, 2005 | 3.316 |
| February 11, 2005 | 3.316 |
| January 24, 2005 | 3.235 |
| January 20, 2005 | 3.235 |
| January 19, 2005 | 3.289 |
| January 18, 2005 | 3.289 |
| January 13, 2005 | 3.289 |
| January 11, 2005 | 2.696 |
| December 31, 2004 | 3.343 |
Price to Sales Ratio Definition
The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.
PS Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PS Ratio Benchmarks
PS Ratio Related Metrics
| Price to Book Value | 0.1653 |
| Price | 0.405 |
| Earnings Yield | -1.90K% |
| Market Cap | 1.510M |